[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100599940":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":38,"centralContacts":42,"locations":48,"responsibleParty":285,"collaborators":10,"id":287,"slug":288,"hasResults":289,"nctId":290,"briefTitle":291,"officialTitle":291,"acronym":292,"eligibilityCriteria":293,"healthyVolunteers":289,"sex":294,"minAge":295,"maxAge":296,"enrollmentInfo":297,"targetDuration":300,"studyType":301,"phases":10,"briefSummary":302,"conditions":303,"keywords":305,"overallStatus":51,"whyStopped":10,"lastUpdateSubmitDate":326,"lastUpdatePostDateStruct":327,"startDateStruct":330,"completionDateStruct":332,"leadSponsor":334,"locationsCount":335},{"fullName":5,"class":6},"Novartis","INDUSTRY",[8,14,18,22,26],{"label":9,"type":10,"description":11,"interventionNames":12},"Asciminib",null,"Patients who started their 1L or 2L asciminib following FDA approval on or after Oct-2024 OR Patients who have exited an asciminib interventional study in US for 1L\u002F2L CML and are continuing treatment with asciminib in routine medical care",[13],"Other: TKIs",{"label":15,"type":10,"description":16,"interventionNames":17},"Bosutinib","Patients who started 1L or 2L bosutinib on or after Oct-2021",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Dasatinib","Patients who started 1L or 2L dasatinib on or after Oct-2021",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Imatinib","Patients who started 1L or 2L imatinib on or after Oct-2021",[13],{"label":27,"type":10,"description":28,"interventionNames":29},"Nilotinib","Patients who started 1L or 2L nilotinib on or after Oct-2021",[13],[31],{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"OTHER","TKIs","There is no treatment allocation for NIS trials. Patients administered TKI (asciminib, bosutinib, dasatinib, imatinib, nilotinib) by prescription will be enrolled.",[9,15,19,23,27],[37],"Scemblix, Bosulif, Sprycel, Gleevec, Tasigna",[39],{"name":40,"affiliation":40,"role":41},"Novartis Pharmaceuticals","STUDY_DIRECTOR",[43,47],{"name":40,"role":44,"phone":45,"phoneExt":10,"email":46},"CONTACT","1-888-669-6682","novartis.email@novartis.com",{"name":40,"role":44,"phone":10,"phoneExt":10,"email":10},[49,69,84,96,109,124,137,152,165,178,190,203,216,231,246,261,275],{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"University of Alabama at Birmingham","RECRUITING","Birmingham","Alabama","35233-0271","United States","US",{"type":58,"coordinates":59},"Point",[60,61],-86.80249,33.52066,{"lat":61,"lon":60},[64,66],{"name":10,"role":44,"phone":65,"phoneExt":10,"email":10},"+1 205 502 9967",{"name":67,"role":68,"phone":10,"phoneExt":10,"email":10},"Omer Jamy","PRINCIPAL_INVESTIGATOR",{"facility":70,"status":51,"city":71,"state":72,"zip":73,"country":55,"countryCode":56,"cosmosGeoPoint":74,"geoPoint":78,"contacts":79},"Stockton Hematology Oncology Medical Group Inc","Stockton","California","95204",{"type":58,"coordinates":75},[76,77],-121.29078,37.9577,{"lat":77,"lon":76},[80,82],{"name":10,"role":44,"phone":81,"phoneExt":10,"email":10},"+1 209 466 2626",{"name":83,"role":68,"phone":10,"phoneExt":10,"email":10},"Ravleen Grewal",{"facility":85,"status":51,"city":86,"state":72,"zip":87,"country":55,"countryCode":56,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"Lundquist Inst BioMed at Harbor","Torrance","90509-2910",{"type":58,"coordinates":89},[90,91],-118.34063,33.83585,{"lat":91,"lon":90},[94],{"name":95,"role":68,"phone":10,"phoneExt":10,"email":10},"Sarah Elizabeth Tomassetti",{"facility":97,"status":51,"city":98,"state":99,"zip":100,"country":55,"countryCode":56,"cosmosGeoPoint":101,"geoPoint":105,"contacts":106},"Stamford Hospital","Stamford","Connecticut","06902",{"type":58,"coordinates":102},[103,104],-73.53873,41.05343,{"lat":104,"lon":103},[107],{"name":108,"role":68,"phone":10,"phoneExt":10,"email":10},"Joshua Dower",{"facility":110,"status":51,"city":111,"state":112,"zip":113,"country":55,"countryCode":56,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Sacred Heart Medical Oncology","Pensacola","Florida","32504",{"type":58,"coordinates":115},[116,117],-87.21691,30.42131,{"lat":117,"lon":116},[120,122],{"name":10,"role":44,"phone":121,"phoneExt":10,"email":10},"+1 850 416 2730",{"name":123,"role":68,"phone":10,"phoneExt":10,"email":10},"Dany El-Sayah",{"facility":125,"status":51,"city":126,"state":127,"zip":128,"country":55,"countryCode":56,"cosmosGeoPoint":129,"geoPoint":133,"contacts":134},"Cancer Care Specialists of Central Illinois","Decatur","Illinois","62526",{"type":58,"coordinates":130},[131,132],-88.9548,39.84031,{"lat":132,"lon":131},[135],{"name":136,"role":68,"phone":10,"phoneExt":10,"email":10},"James Wade",{"facility":138,"status":51,"city":139,"state":140,"zip":141,"country":55,"countryCode":56,"cosmosGeoPoint":142,"geoPoint":146,"contacts":147},"St Agnes Hospital","Baltimore","Maryland","21229",{"type":58,"coordinates":143},[144,145],-76.61219,39.29038,{"lat":145,"lon":144},[148,150],{"name":10,"role":44,"phone":149,"phoneExt":10,"email":10},"+1 410 368 3412",{"name":151,"role":68,"phone":10,"phoneExt":10,"email":10},"Carole Miller",{"facility":153,"status":51,"city":154,"state":155,"zip":156,"country":55,"countryCode":56,"cosmosGeoPoint":157,"geoPoint":161,"contacts":162},"Truman Medical Center","Kansas City","Missouri","64108",{"type":58,"coordinates":158},[159,160],-94.57857,39.09973,{"lat":160,"lon":159},[163],{"name":164,"role":68,"phone":10,"phoneExt":10,"email":10},"Anuj Shrestha",{"facility":166,"status":51,"city":167,"state":168,"zip":169,"country":55,"countryCode":56,"cosmosGeoPoint":170,"geoPoint":174,"contacts":175},"NY Cancer and Blood Specialists","East Setauket","New York","11733",{"type":58,"coordinates":171},[172,173],-73.10594,40.94149,{"lat":173,"lon":172},[176],{"name":177,"role":68,"phone":10,"phoneExt":10,"email":10},"Adam Hines",{"facility":179,"status":51,"city":180,"state":168,"zip":181,"country":55,"countryCode":56,"cosmosGeoPoint":182,"geoPoint":186,"contacts":187},"SUNY Upstate Medical University","Syracuse","13210",{"type":58,"coordinates":183},[184,185],-76.14742,43.04812,{"lat":185,"lon":184},[188],{"name":189,"role":68,"phone":10,"phoneExt":10,"email":10},"Gillian Kupakuwana-Suk",{"facility":191,"status":51,"city":192,"state":193,"zip":194,"country":55,"countryCode":56,"cosmosGeoPoint":195,"geoPoint":199,"contacts":200},"Tri-County Hematology and Oncology Associates","Canton","Ohio","44718",{"type":58,"coordinates":196},[197,198],-81.37845,40.79895,{"lat":198,"lon":197},[201],{"name":202,"role":68,"phone":10,"phoneExt":10,"email":10},"Norman Rafique",{"facility":204,"status":51,"city":205,"state":206,"zip":207,"country":55,"countryCode":56,"cosmosGeoPoint":208,"geoPoint":212,"contacts":213},"Oregon Oncology Specialists Salem","Salem","Oregon","97301",{"type":58,"coordinates":209},[210,211],-123.0351,44.9429,{"lat":211,"lon":210},[214],{"name":215,"role":68,"phone":10,"phoneExt":10,"email":10},"John Strother",{"facility":217,"status":51,"city":218,"state":219,"zip":220,"country":55,"countryCode":56,"cosmosGeoPoint":221,"geoPoint":225,"contacts":226},"Avera Cancer","Sioux Falls","South Dakota","57105",{"type":58,"coordinates":222},[223,224],-96.72796,43.54369,{"lat":224,"lon":223},[227,229],{"name":10,"role":44,"phone":228,"phoneExt":10,"email":10},"+1 605 322 3064",{"name":230,"role":68,"phone":10,"phoneExt":10,"email":10},"Tiffani Kirkpatrick",{"facility":232,"status":51,"city":233,"state":234,"zip":235,"country":55,"countryCode":56,"cosmosGeoPoint":236,"geoPoint":240,"contacts":241},"Baylor Scott and White Research","Temple","Texas","76502",{"type":58,"coordinates":237},[238,239],-97.34278,31.09823,{"lat":239,"lon":238},[242,244],{"name":10,"role":44,"phone":243,"phoneExt":10,"email":10},"+1 254 935 5838",{"name":245,"role":68,"phone":10,"phoneExt":10,"email":10},"Lucas Wong",{"facility":247,"status":51,"city":248,"state":249,"zip":250,"country":55,"countryCode":56,"cosmosGeoPoint":251,"geoPoint":255,"contacts":256},"Fred Hutchinson Cancer Research Center","Seattle","Washington","98109-1024",{"type":58,"coordinates":252},[253,254],-122.33207,47.60621,{"lat":254,"lon":253},[257,259],{"name":10,"role":44,"phone":258,"phoneExt":10,"email":10},"+1 206 667 7315",{"name":260,"role":68,"phone":10,"phoneExt":10,"email":10},"Vivian Oehler",{"facility":262,"status":51,"city":263,"state":249,"zip":264,"country":55,"countryCode":56,"cosmosGeoPoint":265,"geoPoint":269,"contacts":270},"MultiCare Health System Institute","Tacoma","98405",{"type":58,"coordinates":266},[267,268],-122.44429,47.25288,{"lat":268,"lon":267},[271,273],{"name":10,"role":44,"phone":272,"phoneExt":10,"email":10},"+1 253 403 5265",{"name":274,"role":68,"phone":10,"phoneExt":10,"email":10},"Nehal Masood",{"facility":276,"status":51,"city":263,"state":249,"zip":264,"country":55,"countryCode":56,"cosmosGeoPoint":277,"geoPoint":279,"contacts":280},"Northwest Medical Specialties",{"type":58,"coordinates":278},[267,268],{"lat":268,"lon":267},[281,283],{"name":10,"role":44,"phone":282,"phoneExt":10,"email":10},"+1 253 428 8756",{"name":284,"role":68,"phone":10,"phoneExt":10,"email":10},"Ali Dadla",{"type":286,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100599940","a-real-world-chronic-myelogenous-leukemia-cml-patient-disease-registry-to-describe-patient-experience-and-clinical-outcomes-among-patients-with-cml-receiving-approved-first-or-second-line-tyrosine-kinase-inhibitor-tki-therapy-100599940",false,"NCT07091019","A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy","ASC4REAL-2","Inclusion Criteria:\n\n* 18 years or older at the time of Ph+-CML-CP diagnosis.\n* Receiving TKI treatment (asciminib, bosutinib, dasatinib, imatinib, or nilotinib) in routine medical care either as initial therapy or after 1 prior TKI therapy.\n* Receiving treatment at US and US territories (i.e., Puerto Rico) medical practice (e.g. community-based, office-based, hospital-based, academic).\n* Signed informed consent form (ICF) prior to participation in the study including agreement to be tokenized so that the patient's anonymized RWD (EMRs and\u002For claims data) can be accessed.\n\nExclusion Criteria:\n\n* Active participation in an interventional trial that may influence the management of their Ph+-CML-CP disease.\n* Currently being treated with a CML TKI in 3L or beyond.\n* Known presence of T315I mutation.\n* Currently in TFR phase and are not on active CML TKI therapy.\n* Previously received treatment with a prior stem cell transplant\n* Pregnant or nursing (lactating) female.","ALL","18 Years","100 Years",{"count":298,"type":299},1000,"ESTIMATED","5 Years","OBSERVATIONAL","This CML disease registry (ASC4REAL-2) aims to gather evidence on the tolerability, safety, effectiveness, and patient-reported outcomes (PRO) in real-world healthcare from patients with Ph+-CML-CP treated with TKIs approved for 1L and 2L, including prospective follow-up for 5 years identifying and describing long-term treatment outcomes.",[304],"Chronic Myelogenous Leukemia - Chronic Phase",[306,307,308,309,310,311,312,313,314,315,316,317,318,319,320,321,322,323,324,325],"CML,","CMP-CP,","ASC4REAL,","ASC4REAL-2,","chronic phase,","BCR-ABL, MMR,","TKI,","Tyrosine Kinase Inhibitor,","molecular response,","adult,","registry,","PRO,","patient reported outcome,","QOL,","quality of life,","asciminib,","bosutinib,","imatinib,","nilotinib,","dasatinib","2026-07-17",{"date":328,"type":329},"2026-07-20","ACTUAL",{"date":331,"type":329},"2025-12-17",{"date":333,"type":299},"2033-04-20",{"name":40,"class":6},17]